Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening

References

1. 1.↵
   US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564–75.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Wolf A,
   2. Fontham E,
   3. Church TR,
   4. et al

   . Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA A Cancer J Clinicians 2018;68:250–81.

   OpenUrl
3. 3.↵
   1. Imperiale TF,
   2. Ransohoff DF,
   3. Itzkowitz SH,
   4. et al

   . Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287–97.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Hanauer DA

   . EMERSE: The electronic medical record search engine. AMIA Annu Symp Proc 2006;2006:941.

   OpenUrl
5. 5.↵
   1. Agarwal A,
   2. Zhang T,
   3. Ravindran N,
   4. et al

   . Off-label use of multitarget stool DNA testing in primary care. Am J Gastroenterol April 2021;116:829–32.

   OpenUrl
6. 6.↵
   1. Redwood DG,
   2. Dinh TA,
   3. Kisiel JB,
   4. et al

   . Cost effectiveness of multitarget stool DNA testing vs colonoscopy or fecal immunochemical testing for colorectal cancer screening in Alaska Native People. Mayo Clin Proc 2021;96:1203–17.

   OpenUrl
7. 7.↵
   1. Burt RW,
   2. Barthel JS,
   3. Dunn KB,
   4. et al

   . NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010;8:8–61.

   OpenUrlAbstract/FREE Full Text